Why the study?
Does pulmonary endarterectomy (PEA) improve long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH)?
Does pulmonary endarterectomy (PEA) improve long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH)?
This first multicenter prospective registry of CTEPH in China shows survival rates comparable to international cohorts and confirms pulmonary endarterectomy as an independent predictor of survival.
Answers are grounded in this paper and cite their sources.
Supports PEA consideration in CTEPH; extends registry data to China but remains hypothesis-generating.
This is the first multicentre prospective registry reporting baseline characteristics and estimated survival of patients with CTEPH in China. The long-term survival rates are similar to those of patients in the international and Spanish registries. PEA is an independent predictor of survival.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: